StockData

Nu-Med Plus, Inc. (NUMD) stock

NUMDOTCGold and Silver OresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 3/30
$0.01−0.00 (-8.16%)

Close on Oct 19, 2026Market cap $601.55KP/E –Yield –

Nu-Med Plus pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Nu-Med Plus's pe ratio was 13.0× on Jan 31, 2019, against 3.1× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2019Jan 31, 201913.0×−2.0
2018Dec 31, 201815.0×+11.9
2017Dec 29, 20173.1×–

More Nu-Med Plus figures

See a number that looks wrong?